STEPHEN H. EMBURY, M.D.
Osteopathic Medicine at Eagle Trace Dr, Princeton By The Sea, CA
License number
California GFE24444
Category
Osteopathic Medicine
Type
Hematology
Address
Address
108 Eagle Trace Dr, Princeton By The Sea, CA 94019
Phone
(415) 203-0436
(650) 560-0097 (Fax)
(650) 560-0097 (Fax)
Personal information
See more information about STEPHEN H. EMBURY at radaris.comName
Address
Phone
108 Eagle Trace Dr, Half Moon Bay, CA 94019
108 Eagle Trace Dr, Half Moon Bay, CA 94019
Professional information
See more information about STEPHEN H. EMBURY at trustoria.com
Dr. Stephen H Embury, Half Moon Bay CA - MD (Doctor of Medicine)
Dr. Stephen H Embury, Half Moon Bay CA - MD (Doctor of Medicine)
Specialties:
Hematology
Address:
108 Eagle Trace Dr, Half Moon Bay 94019
(415) 203-0436 (Phone), (650) 560-0097 (Fax)
(415) 203-0436 (Phone), (650) 560-0097 (Fax)
Certifications:
Hematology, 1976, Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1968
Wesley Meml Hosp-Northweste
Stanford U Med Ctr
Northwestern Center Feinberg School of Medicine
Graduated: 1968
Wesley Meml Hosp-Northweste
Stanford U Med Ctr
Method And Composition For Preventing Pain In Sickle Cell Patients
Method And Composition For Preventing Pain In Sickle Cell Patients
US Patent:
2008011, May 15, 2008
Filed:
Jan 17, 2008
Appl. No.:
12/015885
Inventors:
STEPHEN EMBURY - Half Moon Bay CA, US
NEIL MATSUI - San Francisco CA, US
NEIL MATSUI - San Francisco CA, US
Assignee:
TRF PHARMA, INC. - Burlingame CA
International Classification:
A61K 39/395, A61K 38/17, A61K 31/704, A61K 31/715, A61K 31/727, A61K 31/428
US Classification:
424133100, 514008000, 514054000, 514056000, 514033000, 514026000, 514367000
Abstract:
A method of preventing pain in a sickle cell patient is disclosed. The method includes orally administering to the patient, an amount of an active agent effective on oral administration to inhibit binding of the patient's sickle erythrocytes to P-selectin on the patient's vascular endothelium. The inhibition may be evidenced in a number of ways. The active agent administration inhibits the adhesion of sickle erythrocytes to vascular endothelium in the patient, thereby preventing patient pain associated with vascular occlusion. Also disclosed are compositions useful in practicing the method.
Method And Composition For Preventing Pain In Sickle Cell Patients
Method And Composition For Preventing Pain In Sickle Cell Patients
US Patent:
2004007, Apr 15, 2004
Filed:
Apr 18, 2003
Appl. No.:
10/418653
Inventors:
Stephen Embury - Half Moon Bay CA, US
Neil Matsui - San Francisco CA, US
Neil Matsui - San Francisco CA, US
International Classification:
A61K031/727
US Classification:
514/056000
Abstract:
A method of preventing pain in a sickle cell patient is disclosed. The method includes orally administering to the patient, an amount of an active agent effective on oral administration to inhibit binding of the patient's sickle erythrocytes to P-selectin on the patient's vascular endothelium. The inhibition may be evidenced in a number of ways. The active agent administration inhibits the adhesion of sickle erythrocytes to vascular endothelium in the patient, thereby preventing patient pain associated with vascular occlusion. Also disclosed are compositions useful in practicing the method.